A detailed history of Moors & Cabot, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 23,237 shares of BAX stock, worth $804,929. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,237
Previous 23,187 0.22%
Holding current value
$804,929
Previous $775,000 13.81%
% of portfolio
0.04%
Previous 0.04%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$32.85 - $40.26 $1,642 - $2,013
50 Added 0.22%
23,237 $882,000
Q2 2024

Aug 09, 2024

SELL
$32.87 - $43.55 $235,250 - $311,687
-7,157 Reduced 23.59%
23,187 $775,000
Q1 2024

May 08, 2024

SELL
$37.88 - $43.77 $15,152 - $17,508
-400 Reduced 1.3%
30,344 $1.3 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $1,522 - $1,869
-48 Reduced 0.16%
30,744 $1.19 Million
Q3 2023

Nov 07, 2023

BUY
$37.32 - $49.29 $68,109 - $89,954
1,825 Added 6.3%
30,792 $1.16 Million
Q2 2023

Aug 09, 2023

BUY
$39.98 - $47.68 $11,194 - $13,350
280 Added 0.98%
28,967 $1.32 Million
Q1 2023

May 04, 2023

BUY
$37.58 - $52.57 $53,025 - $74,176
1,411 Added 5.17%
28,687 $1.16 Million
Q4 2022

Feb 09, 2023

BUY
$49.7 - $57.71 $8,647 - $10,041
174 Added 0.64%
27,276 $1.39 Million
Q4 2022

Feb 06, 2023

SELL
$49.7 - $57.71 $60,683 - $70,463
-1,221 Reduced 4.31%
27,102 $1.38 Million
Q3 2022

Nov 07, 2022

SELL
$53.86 - $66.8 $51,813 - $64,261
-962 Reduced 3.28%
28,323 $1.53 Million
Q2 2022

Aug 08, 2022

BUY
$63.83 - $80.0 $4,021 - $5,040
63 Added 0.22%
29,285 $1.88 Million
Q1 2022

May 13, 2022

SELL
$76.85 - $89.45 $54,563 - $63,509
-710 Reduced 2.37%
29,222 $2.27 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $1,491 - $1,743
-20 Reduced 0.07%
29,932 $2.57 Million
Q3 2021

Dec 08, 2021

SELL
$73.77 - $83.61 $1.69 Million - $1.92 Million
-22,946 Reduced 43.38%
29,952 $2.4 Million
Q3 2021

Nov 05, 2021

BUY
$73.77 - $83.61 $1.72 Million - $1.95 Million
23,357 Added 79.07%
52,898 $1.09 Million
Q2 2021

Aug 10, 2021

BUY
$80.5 - $88.01 $61,985 - $67,767
770 Added 2.68%
29,541 $2.38 Million
Q1 2021

May 12, 2021

SELL
$76.38 - $86.03 $307,200 - $346,012
-4,022 Reduced 12.26%
28,771 $2.42 Million
Q4 2020

Feb 11, 2021

SELL
$75.39 - $82.36 $72,525 - $79,230
-962 Reduced 2.85%
32,793 $2.63 Million
Q3 2020

Nov 09, 2020

SELL
$78.33 - $90.73 $235,694 - $273,006
-3,009 Reduced 8.18%
33,755 $2.72 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $962,877 - $1.15 Million
12,241 Added 49.92%
36,764 $3.16 Million
Q1 2020

May 12, 2020

SELL
$71.57 - $93.3 $1.22 Million - $1.59 Million
-17,060 Reduced 41.03%
24,523 $1.98 Million
Q4 2019

Jan 28, 2020

SELL
$76.7 - $88.45 $68,569 - $79,074
-894 Reduced 2.1%
41,583 $3.48 Million
Q3 2019

Oct 22, 2019

SELL
$81.4 - $89.78 $835,245 - $921,232
-10,261 Reduced 19.46%
42,477 $3.71 Million
Q2 2019

Jul 18, 2019

BUY
$73.44 - $82.41 $47,736 - $53,566
650 Added 1.25%
52,738 $4.32 Million
Q1 2019

May 06, 2019

SELL
$64.48 - $81.31 $3.36 Million - $4.24 Million
-52,088 Reduced 50.0%
52,088 $4.23 Million
Q1 2019

May 01, 2019

BUY
$64.48 - $81.31 $3.3 Million - $4.16 Million
51,218 Added 96.71%
104,176 $8.46 Million
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $57,332 - $72,587
-933 Reduced 1.73%
52,958 $3.49 Million
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $11,313 - $12,440
160 Added 0.3%
53,891 $4.15 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $172,846 - $205,492
-2,725 Reduced 4.83%
53,731 $3.97 Million
Q1 2018

May 18, 2018

SELL
$62.56 - $72.26 $4,692 - $5,419
-75 Reduced 0.13%
56,456 $3.67 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $192,031 - $206,406
-3,125 Reduced 5.24%
56,531 $3.65 Million
Q3 2017

Nov 16, 2017

BUY
$59.5 - $64.61 $16,362 - $17,767
275 Added 0.46%
59,656 $3.75 Million
Q2 2017

Aug 15, 2017

BUY
N/A
59,381
59,381 $3.59 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.